BioChain Institute, Inc.
39600 Eureka Drive
Newark
CA
94560
United States
Tel: 510-783-8588
Website: http://www.biochain.com/
Email: info@biochain.com
About BioChain Institute, Inc.
BioChain, founded in 1994 and headquartered in San Francisco Bay Area, is the world leader in high quality processed bio-sample products and analysis services used in advancing translational medicine, companion diagnostics, and clinical product research and development. BioChain also provides Biospecimens including tissue sections, panels, arrays, as well as gDNA, RNA and protein lysate from our tissue bank. We provide a variety of nucleic acid and protein lysate extraction and analysis kits as well as automated nucleic acid extraction equipment. BioChain can perform custom projects - including tissue procurement, custom nucleic acid or protein extractions. BioChain established a comprehensive quality assurance program to meet our customers' satisfactions as well as maintaining both ISO 9001:2015 and ISO 13485:2003 certifications for our in house production facilities.
Our other focus has been in developing and licensing early cancer diagnostics technologies through liquid biopsy. In our US research facility, we developed and successfully launched our liquid biopsy cfPure® cell-free DNA extraction kit and our vamPureTM whole blood DNA extraction kit. BioChain is a One-Stop Service company for all Next Generation Sequencing projects, from clinical sample collection, sample preparation, sequencing to bioinformatics analysis.
12 articles about BioChain Institute, Inc.
-
BioChain is officially a 10X Visium Certified Service Provider for spatial multiomics products and services
9/16/2022
BioChain Institute Inc., ("BioChain"), a leader in high-quality processed bio-sample products and services, is excited to officially be a 10X Visium Certified Service Provider, providing custom-tailored whole transcriptome services and off the shelf Visium characterized tissues, further expanding its spatial biology catalog.
-
BioChain announces partnership with Nanostring to provide Spatial Multiomics Services
4/26/2022
BioChain Institute, a leader in high-quality processed bio-sample products is excited to adopt GeoMx platform to provide digital spatial profiling services.
-
BioChain announces expanded line of NGS characterized bio-samples for oncology researchers
9/22/2021
BioChain Institute, a leader in high quality processed bio-sample products, announced an expanded line of Next Generation Sequencing characterized bio-samples encompassing a variety of cancer-related mutations available for preclinical drug development and as reference samples for CLIA labs.
-
BioChain: FFPE/Fresh Frozen BRCA I/II Characterized Breast Tissue
8/16/2021
BioChain is expanding its current product line of NGS-characterized bio-samples by offering ready-to-use BRCA-characterized FFPE/frozen sections/blocks for preclinical drug development and as reference samples for CLIA labs.
-
BioChain: Pioneers in Providing High Quality Testing Reagents in the Fight Against COVID-19
3/16/2021
Today BioChain announced it has successfully provided enough reagents to test over 3,000,000 people across the United States for COVID-19 infection.
-
BioChain Responds to Epigenomics' unilateral termination of license contract
3/12/2019
The termination of the contract by Epigenomics is not legally effective.
-
BioChain Responds to Epigenomics' Unilateral Termination of License Contract - March 12, 2019
3/12/2019
BioChain, a US-based company, said Epigenomics AG of Germany seriously violated the terms of an ongoing licensing contract by publicly announcing on March 6, 2019 the unilateral termination of BioChain’s licensing right of Septin9 marker in China.
-
Epigenomics AG Raises USD 5.3 Million From Its Strategic Commercialization Partner Biochain Institute, Inc.
10/16/2014
-
ChinaBio(R) LLC Week in Review: Three China In-Licensings and One Nixed Intra-China Deal
11/4/2013
-
Epigenomics AG Signs Licensing Agreement With Biochain Institute, Inc. for Septin9 in China
3/7/2013
-
Biochain Institute, Inc. Launches MicroRNA Signature Validation Kits and Services
10/14/2010
-
Biochain Institute, Inc. Launches Colon Cancer Frozen Tissue Array
10/11/2010